Clinical Trial Update: One vs Two Weeks Treatment for H.Pylori Eradication A RANDOMIZED NON-INFERIORITY PLACEBO CONTROLLED TRIAL [Phase 3]

View source ↗

Summary

A Phase 3 randomized non-inferiority trial comparing one-week versus two-week treatment for Helicobacter pylori eradication with a placebo control.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: Aga Khan University | Conditions: Helicobacter Pylori Infection | Phase 3 | Status: UNKNOWN